SPINAL CORD INJURY
Mesenchymal Stem Cells for Spinal Cord Injury
Spinal cord injury (SCI) has considerable impact on patient physical, mental, and financial health. Secondary SCI is associated with inflammation, vascular destruction, and subsequent permanent damage to the nervous system. Mesenchymal stem cells (MSCs) have anti-inflammatory properties, promoting vascular regeneration and the release neuro-nutrients.
MSCs have been reported to improve the American Spinal Injury Association (ASIA) sensory and motor scores.
The ability of MSCs to improve ASIA sensory and motor scores and promote bladder function recovery and neurological symptom recovery in patients with SCI has been widely demonstrated.
Current evidence showed that 70% of patients with spinal cord injury (SCI) could benefit from stem cell therapy.
General Information
A blood sample from the patient is required at least 3 hours before the procedure to sensitize the MSC’s with the patient’s serum. Preferably take a blood sample 1 day before. When the patient is local and only has treatment with MSC’s, it may be easier to schedule the patient to come for sampling one day prior to their MSC’s treatment.
*Important; patients must pay in full 5 days prior to their scheduled treatment date to ensure fresh mesenchymal stem cells.
None of the patients have had any side effects as a result of the administration of mesenchymal stem cells.
